27338082 30604182 27835801 23727505 31758947 28838808 34500853 35160010 30833484 29533978 26081302 27074934 27513693 25037227 31013934 34102966 24292824 28750807 25131716 27231154 32595453 24090766 32774241 25123645 36413346 23541635 26845176 2577903 - Search Results

Year	Number of Results
2012	1
2013	5
2014	8
2015	8
2016	14
2017	10
2018	2
2019	10
2020	8
2021	11
2022	6
2023	1

1

The Multiple Waves of Cannabinoid 1 Receptor Signaling.

Nogueras-Ortiz C, Yudowski GA. Nogueras-Ortiz C, et al. Mol Pharmacol. 2016 Nov;90(5):620-626. doi: 10.1124/mol.116.104539. Epub 2016 Jun 23. Mol Pharmacol. 2016. PMID: 27338082 Review.

2

Tempering aversive/traumatic memories with cannabinoids: a review of evidence from animal and human studies.

Lisboa SF, Vila-Verde C, Rosa J, Uliana DL, Stern CAJ, Bertoglio LJ, Resstel LB, Guimaraes FS. Lisboa SF, et al. Psychopharmacology (Berl). 2019 Jan;236(1):201-226. doi: 10.1007/s00213-018-5127-x. Epub 2019 Jan 2. Psychopharmacology (Berl). 2019. PMID: 30604182 Review.

3

Cannabinoid receptor ligand bias: implications in the central nervous system.

Laprairie RB, Bagher AM, Denovan-Wright EM. Laprairie RB, et al. Curr Opin Pharmacol. 2017 Feb;32:32-43. doi: 10.1016/j.coph.2016.10.005. Epub 2016 Nov 9. Curr Opin Pharmacol. 2017. PMID: 27835801 Review.

4

Dysregulation of cannabinoid CB1 receptor and associated signaling networks in brains of cocaine addicts and cocaine-treated rodents.

Álvaro-Bartolomé M, García-Sevilla JA. Álvaro-Bartolomé M, et al. Neuroscience. 2013 Sep 5;247:294-308. doi: 10.1016/j.neuroscience.2013.05.035. Epub 2013 May 29. Neuroscience. 2013. PMID: 23727505

5

c-Jun N terminal kinase signaling pathways mediate cannabinoid tolerance in an agonist-specific manner.

Henderson-Redmond AN, Nealon CM, Davis BJ, Yuill MB, Sepulveda DE, Blanton HL, Piscura MK, Zee ML, Haskins CP, Marcus DJ, Mackie K, Guindon J, Morgan DJ. Henderson-Redmond AN, et al. Neuropharmacology. 2020 Mar 1;164:107847. doi: 10.1016/j.neuropharm.2019.107847. Epub 2019 Nov 20. Neuropharmacology. 2020. PMID: 31758947 Free PMC article.

6

Characterization of structurally novel G protein biased CB₁ agonists: Implications for drug development.

Ford BM, Franks LN, Tai S, Fantegrossi WE, Stahl EL, Berquist MD, Cabanlong CV, Wilson CD, Penthala NR, Crooks PA, Prather PL. Ford BM, et al. Pharmacol Res. 2017 Nov;125(Pt B):161-177. doi: 10.1016/j.phrs.2017.08.008. Epub 2017 Aug 23. Pharmacol Res. 2017. PMID: 28838808 Free PMC article.

7

CB1 Cannabinoid Receptor Signaling and Biased Signaling.

Leo LM, Abood ME. Leo LM, et al. Molecules. 2021 Sep 6;26(17):5413. doi: 10.3390/molecules26175413. Molecules. 2021. PMID: 34500853 Free PMC article. Review.

8

Considerations for Cannabinoids in Perioperative Care by Anesthesiologists.

Laudanski K, Wain J. Laudanski K, et al. J Clin Med. 2022 Jan 22;11(3):558. doi: 10.3390/jcm11030558. J Clin Med. 2022. PMID: 35160010 Free PMC article. Review.

9

Reduced Tolerance and Asymmetrical Crosstolerance to Effects of the Indole Quinuclidinone Analog PNR-4-20, a G Protein-Biased Cannabinoid 1 Receptor Agonist in Mice: Comparisons with Δ⁹-Tetrahydrocannabinol and JWH-018.

Ford BM, Cabanlong CV, Tai S, Franks LN, Penthala NR, Crooks PA, Prather PL, Fantegrossi WE. Ford BM, et al. J Pharmacol Exp Ther. 2019 May;369(2):259-269. doi: 10.1124/jpet.118.252965. Epub 2019 Mar 4. J Pharmacol Exp Ther. 2019. PMID: 30833484 Free PMC article.

10

Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System.

Zou S, Kumar U. Zou S, et al. Int J Mol Sci. 2018 Mar 13;19(3):833. doi: 10.3390/ijms19030833. Int J Mol Sci. 2018. PMID: 29533978 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results